Use of differential normal pulse voltammetry for the measurement of locus coeruleus catecholaminergic metabolism in an acute anaesthetized rodent model of allodynia: Effect of mexiletine

Journal of Neuroscience Methods

Volumn 76, Issue 1, 1997, Pages 21-28

  Duggan, Scott ^a   Milne, Brian ^a,b   Loomis, Christopher ^c  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Allodynia; Glycine; Locus coeruleus; Mexiletine; Spinal cord; Strychnine; Voltammetry

Indexed keywords

BIOCHEMICAL MARKER; GLYCINE; GLYCINE RECEPTOR; MEXILETINE; STRYCHNINE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR EFFECT; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; DOSE RESPONSE; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; NEUROPATHY; NONHUMAN; PAIN ASSESSMENT; POTENTIOMETRY; PRIORITY JOURNAL; RAT; SOMATOSENSORY SYSTEM; SPINAL CORD;

ANESTHESIA; ANESTHETICS, LOCAL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CATECHOLAMINES; ELECTRODES, IMPLANTED; ELECTROPHYSIOLOGY; GLYCINE AGENTS; LIDOCAINE; LOCUS COERULEUS; MALE; MEXILETINE; OXIDATION-REDUCTION; PAIN; RATS; RATS, SPRAGUE-DAWLEY; STRYCHNINE;

EID: 0030856693     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(97)00075-7     Document Type: Article

References (35)

1. Adams RN. In vivo electrochemical measurements in the CNS. Prog Neurobiol 1990;35:297-311.
2. Beyer C, Banas C, Gomora P, Komisaruk BR. Prevention of the convulsant and hyperalgesic action of strychnine by intrathecal glycine and related amino acids. Pharmacol Biochem Behav 1988;29:73-8.
3. Beyer C, Roberts LA, Komisaruk BR. Hyperalgesia induced by altered glycinergic activity at the spinal cord. Life Sci 1985;37:875-82.
4. Bigger, JT, Hoffman, BF, 1990. Antiarrhythmic Drugs. In: Goodman. Gilman, A, Rall, TW, Nies, AS, Taylor, P, editors. The Pharmacological Basis of Therapeutics. New York: Pergamon Press, 1990:857.
5. Buda M, De Simoni G, Gonon F, Pujol JF. Catecholamine metabolism in the rat locus coeruleus as studied by in vivo differential pulse voltammetry. I. Nature and origin of contributors to the oxidation current at +0.1 V. Brain Res 1983;273:197-206.
6. Buda, M, Gonon, FG. Study of brain noradrenergic neurons by use of in vivo voltammetry. In: Justice, JB, editor. Voltammetry in the Neurosciences. Clifton, NJ: Humana Press, 1987: 239-272.
7. Cedarbaum JM, Aghajanian GK. Activation of the locus coeruleus by peripheral stimuli: modulation by a collateral inhibitory mechanism. Life Sci 1978;23:1383-92.
8. Chabal C, Jacobson L, Mariano A, Chaney E, Britell CW. The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology 1992;76:513-7.
9. Dahlstrom A, Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand 1964;62:1-55.
10. Dejgard A, Petersen P, Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1988;29:9-11.
11. DiFazio CA, Niederlehner JR, Burney RG. The anaesthetic potency of lidocaine in the rat. Anesth Analg 1976;55:818-21.
12. Gonon, F, Buda, M, Pujol, JF. Treated carbon fibre electrodes for measuring catechols and ascorbic acid in measurement of neurotransmitter release in vivo. Wiley, New York, 1984a.
13. Gonon FG, Navarre F, Buda MJ. In vivo monitoring of dopamine release in the rat brain with differential normal pulse voltammetry. Anal Chem 1984b;56:573-5.
14. Hegarty A, Portenoy RK. Pharmacotherapy of neuropathic pain. Semin. Neurol. 1994;14:213-24.
15. Hong M, Milne B, Loomis CW, Jhamandas K. In vivo catechol activity in rat locus coeruleus following different nociceptive stimuli and naloxone. Can J Physiol Pharmacol 1992;70:1082-9.
16. Khandwala H, Hodge E, Loomis CW. Comparable dose-dependent inhibition of AP-7 sensitive strychnine-induced allodynia and paw-pinch-induced nociception by mexiletine in the rat. Pain 1997, (in press).
17. Marsden CA, Joseph MH, Kruk ZC, Maidment NT, O'Neill RD, Schenk JO, Stamford JA. In vivo voltammetry-present electrodes and methods. Neuroscience 1988;25:389-400.
18. Merskey H. Classification of chronic pain. Part II. Pain 1986;3 (Suppl):S215-21.
19. Milne B, Duggan S, Jhamandas K, Loomis CW. Innocuous hair deflection evokes a nociceptive-like activation of catechol oxidation in the rat locus coeruleus following intrathecal strychnine: a biochemical index of allodynia using in vivo voltammetry. Brain Res 1996;718:198-202.
20. Onaka M, Minami T, Nishihara I, Ito S. Involvement of glutamate receptors in strychnine- and bicuculline-induced allodynia in conscious mice. Anesthesiology 1996;84:1215-22.
21. Ortemann C, Robert F, Renaud B, Lambas-Senas L. In vivo microdialysis study of the extracellular 3,4-dihydroxyphenylacetic acid in the rat locus coeruleus: topographical and pharmacological aspects. J Neurochem 1993;61:594-601.
22. Paxinos, G, Watson, C. The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
23. Quintin L, Hilaire G, Pujol JF. Variations in dopac concentration are correlated to single cell firing changes in the rat locus coeruleus. Neuroscience 1986;18:889-99.
24. Quintin L, Gillon JY, Saunier CF, Chouvet G, Ghignone M. Continuous volume infusion improves circulatory stability in anaesthetized rats. J Neurosci Methods 1989;30:77-83.
25. Saper CB. Function of the locus coeruleus. TINS 1987;10:343-4.
26. Sherman SE, Loomis CW. Morphine insensitive allodynia is produced by intrathecal strychnine in the lightly anaesthetized rat. Pain 1994;56:17-29.
27. Sherman SE, Loomis CW. Strychnine-dependent allodynia in the urethane-anaesthetized rats is segmentally distributed and prevented by intrathecal glycine and betaine. Can J Physiol Pharmacol 1995;73:1698-705.
28. Sherman SE, Loomis CW. Strychnine sensitive modulation is selective for non-noxious somatosensory input in the spinal cord of the rat. Pain 1996;66:321-30.
29. A, serotonin, or opiate receptors, augments responsiveness of locus coeruleus neurons to excitatory stimulation. Neuropharmacology 1989;28:651-60.
30. Sosnowski M, Yaksh TL. Role of spinal adenosine receptors in modulating the hyperesthesia produced by glycine receptor antagonism. Anesth Analg 1989;69:587-92.
31. Suaud-Chagny MF, Cespuglio R, Rivot JP, Buda M, Gonon F. High sensitivity measurement of brain catechols and indoles in vivo using electrochemically treated carbon-fiber electrodes. J Neurosci Methods 1993;48:241-50.
32. Svensson TH, Thoren P. Brain adrenergic neurons in the locus coeruleus: inhibition by blood volume load through vagal afferents. Brain Res 1979;172:174-8.
33. Valentino RJ, Wehby RG. Morphine effects on locus coeruleus neurons are dependent on the state of arousal and availability of external stimuli: studies in anesthetized and unanesthetized rats. J Pharmacol Exp Ther 1988;244:1178-86.
34. Xu XJ, Hao JX, Seiger A, Arner S, Lindblom U, Wiesenfeld-Hallin Z. Systemic mexiletine relieves chronic allodynia-like symptoms in rats with ischemic spinal cord injury. Anesth Analg 1992;74:649-52.
35. Yaksh TL. Behavioural and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989;37:111-23.